GPC
35
-2
CVS
40
7
DNB
60
-8
ABT
57
-3
WBA
69
26
PH
53
-4
HD
40
3
EXPD
20
-3
GOOG
61
-4
MSFT
39
-4
MAC
40
-8
EW
36
-8
HPE
53
15
UHS
54
-6
ES
28
12
ORLY
41
-3
HP
56
4
TMO
59
-3
FLR
46
-2
AFL
34
-8
GPC
35
-2
CVS
40
7
DNB
60
-8
ABT
57
-3
WBA
69
26
PH
53
-4
HD
40
3
EXPD
20
-3
GOOG
61
-4
MSFT
39
-4
MAC
40
-8
EW
36
-8
HPE
53
15
UHS
54
-6
ES
28
12
ORLY
41
-3
HP
56
4
TMO
59
-3
FLR
46
-2
AFL
34
-8
Financhill
Back

Beam Therapeutics Stock Predictions

Try a Free Stock Analysis With Definitive Buy Sell Hold Ratings

Analyze Any Stock Free
Sell
47

BEAM
Beam Therapeutics

Last Price:
$26.38
Seasonality Move:
-20.08%

7 Day Trial

ALL ACCESS PASS

$ 7

Unlock the power of "two-minute trades"

Learn how today!

Beam Therapeutics Stock Forecast

  • Over the next 52 weeks, Beam Therapeutics has on average historically fallen by 27.1% based on the past 4 years of stock performance.
  • Beam Therapeutics has fallen lower in 4 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 100%
  • Is Beam Therapeutics Stock Undervalued?
    The current Beam Therapeutics [BEAM] share price is $26.39. The Score for BEAM is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
  • BEAM is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Beam Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Beam Therapeutics has on average historically fallen by 27.1% based on the past 4 years of stock performance.

Beam Therapeutics Stock Rating

Sell
47
Beam Therapeutics (BEAM) is a Sell

Is Beam Therapeutics overpriced?

  • Beam Therapeutics has fallen lower in 4 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 100%

Beam Therapeutics Stock Price History

Is BEAM stock going to rise?

  • The current trend is relatively stagnant and BEAM is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
beamtx.com

52-Week Data

52-Week High:
49.50
52-Week Low:
20.84

Prediction Charts

Market Cap:
2.2B
Price in USD:
26.39
Volume:
1.6M
Beta:
1.84

Technical Analysis

SMA50:
26.35
SMA100:
25.45
SMA200:
25.50
52-Wk Change:
-2.55%

Stock Predictions

  • Is Beam Therapeutics stock public?
    Yes, Beam Therapeutics is a publicly traded company.
  • What is the Beam Therapeutics stock quote today?
    The Beam Therapeutics stock price is 26.39 USD today.
  • How to buy Beam Therapeutics stock online?
    You can buy Beam Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-19 25.99 26.85 27.20 24.96
Dec-20 26.90 29.04 29.20 26.74
Dec-23 29.25 28.70 29.52 28.30
Dec-24 28.77 28.81 29.12 28.00
Dec-26 28.41 28.70 29.11 27.75
Dec-27 28.57 26.59 28.75 26.42
Dec-30 26.26 25.27 26.41 24.77
Dec-31 25.45 24.80 25.64 24.71
Jan-2 24.82 24.70 25.02 24.18
Jan-3 24.90 25.38 26.20 24.66
Jan-6 25.58 26.36 27.00 24.76
Jan-7 27.02 27.08 28.39 26.65
Jan-8 26.84 26.80 27.82 25.94
Jan-10 25.94 26.39 27.05 25.59

Beam Therapeutics Earnings

Beam Therapeutics Earnings Report: Per Share Beam Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Beam Therapeutics Forecast Revenue Growth

Beam Therapeutics Stock Analysis: Historical quarterly revenues per share for Beam Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.02 per share, and an increase next year of $0.19 per share.

* Beam Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.